KHA and response. KHA and response. KHA includes AKI history, BP, CKD, serum Creatinine level, Drug list, and urine Dipstick (ABCD). Exposures include.

Slides:

Advertisements

Similar presentations

Acute Kidney Injury. 100,000 deaths are year are associated with acute kidney injury. (NCEPOD 2009)

Advertisements

Figure 4 Interplay between acute kidney injury (AKI),

Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.

Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.

Jeremiah S. Hinson, MD, PhD, Michael R. Ehmann, MD, MPH, MS, Derek M

Volume 70, Issue 8, Pages (October 2006)

Contrast-Induced Acute Kidney Injury: Specialty-Specific Protocols for Interventional Radiology, Diagnostic Computed Tomography Radiology, and Interventional.

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

Figure 2 The continuum of acute kidney injury (AKI),

Section 4: Contrast-induced AKI

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Section 3: Prevention and Treatment of AKI

Chapter 3: Management of progression and complications of CKD

Differing renal outcomes associated with AKI electronic alerts for clinical location of AKI subsets. Differing renal outcomes associated with AKI electronic.

Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Volume 73, Issue 5, Pages (March 2008)

Study flow diagram. aPatients were excluded in order as listed

Incidence of contrast-induced nephropathy in patients with CKD, normal kidney function and all patients. Incidence of contrast-induced nephropathy in patients.

Conceptual model of the course of chronic kidney disease (CKD).

Causes of AKI. The causes of AKI are nonexclusive.

Drug levels during the course of a dosing interval.

(A) Mean (SD) serum continuous erythropoietin receptor activator (C. E

Seven-year cumulative incidence of ESRD according to baseline creatinine clearance (Ccr) and result of urine test for proteinuria (19). Seven-year cumulative.

Urine pH in different disorders.

A glomerulus from a patient who developed nephrotic syndrome while receiving a nonsteroidal anti-inflammatory drug for arthritis. A glomerulus from a patient.

Section 4: Contrast-induced AKI

In-hospital outcomes: community- versus hospital-acquired AKI

Intrapatient variability in cyclosporine blood levels in renal transplant patients. Intrapatient variability in cyclosporine blood levels in renal transplant.

Proteinuria trend versus time for seven patients who achieved remission with adrenocorticotropic hormone (ACTH). Proteinuria trend versus time for seven.

Ionized-to-total magnesium (Mg) and calcium (Ca) ratios are lower in patients on hemodialysis than those in patients not on dialysis. Ionized-to-total.

Drug factors associated with increased risk for nephrotoxicity.

Mean plasma concentrations of ampicillin/sulbactam in plasma of critically ill patients with AKI undergoing extended dialysis (duration depicted by box.

Ca2+ infusion rates during all three protocol versions.

PTH response to the predialysis serum calcium concentration in hemodialysis patients with severe (A), moderate (B), and mild (C) hyperparathyroidism. PTH.

Area under the curve (AUC)–targeted dosing of carboplatin using either the Cockcroft–Gault formula or the Chronic Kidney Disease Epidemiology Collaboration.

A loading dose decreases the time to achieve the target concentration.

Clinical characteristics and laboratory parameters in relation to dose of oral sodium bicarbonate. Clinical characteristics and laboratory parameters in.

Patient factors that increase risk for drug-induced nephrotoxicity.

Potential links between the immune dysfunction in uremia, inflammation, infection, and increased risk of atherosclerosis and cardiovascular disease. Potential.

Mortality predictability of the difference of the percentiles of the changes in dietary protein intake, represented by nPNA (nPCR), and serum P concentration.

Graph showing percentage of total patients with PTD or IGT that would be detected in each category of FBG if an oral glucose tolerance test were performed.

Six-month change in proteinuria predicts risk for ESRD

Combination angiotensin-converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB) reduced risk for renal end point versus ACEI or ARB. Effect.

Potential roles of biomarkers

Representative electron microscopic image from a patient with SMGN

Risk for chronic kidney disease (CKD) among Olmsted County, MN, stone formers and control subjects. Risk for chronic kidney disease (CKD) among Olmsted.

Mortality caused by cardiovascular disease (A) and sepsis (B) of patients with end-stage renal disease (ESRD) treated by dialysis compared with the general.

Cumulative mortality risk in patients with 48-h blood urea nitrogen (BUN) levels of ≥8 mg/dl or

We identified 200 Android and 178 iOS apps using 4 search terms and narrowed this to 12 Android apps, 11 iOS apps, and 5 dual-platform apps after applying.

Distribution of percent consistent facility aspirin use.

New dialysis starts in the United States by year in patients with and without diagnosis of diabetes. New dialysis starts in the United States by year in.

Pathophysiology of acute decompensated heart failure

Analysis of secreted proteins in the discovery panel.

Causal diagrams that represent three possible relationships between smoking, ESRD, and albumin-to-creatinine ratio (ACR) in the Study of Heart and Renal.

Separation in achieved BP levels between the two intervention groups in the SPRINT participants with CKD. The broken line and open circles denote the intensive.

Effect of methylprednisolone versus placebo on the risk of acute kidney injury in a subsample of patients with serial postoperative serum creatinine assessments.

Distribution of SDS for serum creatinine, serum BUN, SBP, and DBP per quintiles of KS. Quintiles are expressed in SDS (see Figure 1B): 1st quintile,

Annual prevalence of proteinuria, hematuria, and combined proteinuria/hematuria on first screening in junior high school children in Tokyo, Japan between.

As the patient nears the end of life (dashed arrow), there is an increasing focus on symptom control and patient goals of care and a shift in the approach.

Grayscale ultrasonographic image in CKD

Dose adjustments in patients with CKD are based on the change in the concentration-time profile for the drug of interest. Dose adjustments in patients.

Dosage-response gradient for colorectal cancer according to serum 25-hydroxyvitamin D [25(OH)D] concentration of five studies combined. Dosage-response.

The Nagi, National Health and Aging Trends Study (NHATS), and International Classification of Functioning, Disability, and Health models for measurement.

Significant correlation between the initial urine osmolality (Uosm T0) and the variation in plasma sodium (DPNa) after 2 L of isotonic saline in 17 patients.

Simplistic breakdown of the new MPGN classification using immunofluorescence as the basis and an approach to evaluation when the kidney biopsy indicated.

The diagram shows the manner in which remodeling can modify the cross-sections of blood vessels. The diagram shows the manner in which remodeling can modify.

Increased incidence rate ratio (IRR) and 95% confidence intervals (CI) for type-specific community-acquired infections across eGFR categories within 12.

Complement factor H (CFH) antibody (Ab) titer of five patients with atypical hemolytic uremic syndrome who were positive for CFH antibody and had homozygous.

Renal angina threshold as a function of predisposition to develop AKI in adults. §Patients with septic shock or patients receiving vasopressors and mechanical.

Presentation transcript:

KHA and response. KHA and response. KHA includes AKI history, BP, CKD, serum Creatinine level, Drug list, and urine Dipstick (ABCD). Exposures include Nephrotoxic Medications, Imaging, Surgery, Sickness (NISS). KHR (4Ms) that encompasses Medication review to withhold unnecessary medications (e.g., nonsteroidal anti-inflammatory drugs [16,17]), the Minimization of nephrotoxic exposures (e.g., intravenous contrast [18]), Messaging the healthcare team and patient to alert the high risk of AKI, and Monitoring for AKI and its consequences. Reprinted from Acute disease quality initiative (ADQI) (12), with permission. Kianoush Kashani et al. CJASN doi:10.2215/CJN.01250119 ©2019 by American Society of Nephrology